ZNF598
Basic information
Region (hg38): 16:1997654-2009821
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZNF598 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 26 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 5 | 0 |
Variants in ZNF598
This is a list of pathogenic ClinVar variants found in the ZNF598 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-1998452-G-A | not specified | Uncertain significance (Sep 22, 2023) | ||
16-1998546-C-T | not specified | Uncertain significance (Apr 24, 2023) | ||
16-1998572-G-A | not specified | Uncertain significance (May 27, 2022) | ||
16-1998725-T-C | not specified | Uncertain significance (Jul 08, 2022) | ||
16-1998977-G-A | not specified | Uncertain significance (Mar 30, 2024) | ||
16-1998986-G-A | not specified | Uncertain significance (Mar 28, 2022) | ||
16-1998999-C-G | not specified | Uncertain significance (May 29, 2024) | ||
16-1999022-A-G | not specified | Uncertain significance (May 31, 2023) | ||
16-1999040-G-A | not specified | Uncertain significance (Feb 22, 2024) | ||
16-1999044-G-A | not specified | Uncertain significance (Apr 26, 2023) | ||
16-1999535-G-A | not specified | Uncertain significance (Jan 26, 2023) | ||
16-1999556-G-A | not specified | Uncertain significance (Mar 28, 2024) | ||
16-1999630-G-A | Likely benign (Feb 01, 2023) | |||
16-1999659-G-A | Likely benign (Dec 01, 2022) | |||
16-1999730-G-A | not specified | Uncertain significance (Sep 07, 2022) | ||
16-1999765-G-A | not specified | Uncertain significance (May 05, 2023) | ||
16-1999768-C-T | not specified | Uncertain significance (Mar 07, 2024) | ||
16-1999773-T-G | not specified | Uncertain significance (Nov 21, 2022) | ||
16-1999834-G-C | not specified | Uncertain significance (Sep 27, 2022) | ||
16-1999837-C-T | not specified | Uncertain significance (May 21, 2024) | ||
16-1999852-C-G | not specified | Uncertain significance (Mar 01, 2023) | ||
16-1999909-G-A | not specified | Likely benign (Feb 22, 2023) | ||
16-1999991-G-C | not specified | Uncertain significance (Apr 07, 2023) | ||
16-2000086-G-A | not specified | Uncertain significance (May 15, 2024) | ||
16-2000111-C-T | not specified | Likely benign (Jul 19, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZNF598 | protein_coding | protein_coding | ENST00000431526 | 14 | 12170 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.548 | 0.452 | 124397 | 0 | 7 | 124404 | 0.0000281 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.924 | 590 | 530 | 1.11 | 0.0000373 | 5726 |
Missense in Polyphen | 182 | 209.06 | 0.87055 | 2364 | ||
Synonymous | -4.48 | 319 | 232 | 1.37 | 0.0000175 | 1804 |
Loss of Function | 4.19 | 7 | 32.9 | 0.213 | 0.00000165 | 393 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000384 | 0.0000355 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000167 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase that plays a key role in the ribosome quality control (RQC), a pathway that takes place when a ribosome has stalled during translation (PubMed:28065601, PubMed:28132843). Required for ribosomes to terminally stall during translation of poly(A) sequences by mediating monoubiquitination of 40S ribosomal protein RPS10/eS10, RPS20/uS10 and RPS3/uS3 (PubMed:28065601, PubMed:28132843). Stalling precludes synthesis of a long poly-lysine tail and initiates the RQC pathway to degrade the potentially detrimental aberrant nascent polypeptide (PubMed:28065601, PubMed:28132843). Also acts as a component of the 4EHP-GYF2 complex, a multiprotein complex that acts as a repressor of translation initiation (PubMed:22751931). {ECO:0000269|PubMed:22751931, ECO:0000269|PubMed:28065601, ECO:0000269|PubMed:28132843}.;
Haploinsufficiency Scores
- pHI
- 0.451
- hipred
- N
- hipred_score
- 0.492
- ghis
- 0.589
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.367
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Zfp598
- Phenotype
Gene ontology
- Biological process
- protein monoubiquitination;protein ubiquitination;rescue of stalled ribosome
- Cellular component
- Molecular function
- RNA binding;protein binding;ribosome binding;metal ion binding;ubiquitin protein ligase activity